Events

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide. See below for a list of past and upcoming events.

EUFEMED, 3rd Annual Conference, 28-30 April 2021

Event Date:
28-30 April 2021
Location:
Virtual Meeting

Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.

View Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Event Date:
4 – 5 December 2020
Location:
Virtual Meeting

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.

View Event

Association for Human Pharmacology in the Pharmaceutical Industry Christmas Lecture

Event Date:
15 December 2020, 14:00 – 16:30 (GMT)
Location:
Virtual Meeting

This year’s lectures will include a presentation by Richmond Pharmacology’s CEO and Founder, Jorg Taubel M.D.

View Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

Event Date:
21 - 23 September 2020
Location:
Virtual Meeting

Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.

View Event

On Helix, Transforming new medicine discovery

Event Date:
13-14 July 2020
Location:
Digital

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.

View Event

Cardiac Safety London

Event Date:
Wednesday 20th May 2020 - 10am – 3.30pm BST
Location:
Online Event

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss the latest state of the art methods...

View Event

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

What 20 years of clinical research has taught us about our industry and the future of drug development

June 9, 2021
As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.
Read more

Do we still need challenge trials with COVID-19?

April 21, 2021
Nir Eyal and colleagues suggested that the initiation of COVID-19 challenge trials in response to the UK governments’ call in 2020 remained relevant and important despite the development of approved vaccines and the introduction of an aggressive, UK-wide vaccination policy.
Read more

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more